382P - Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy
| Autor: | Boucher, D., Hillier, S., Newsome, D., Wang, Y., Takemoto, D., Gu, Y., Markland, W., Hoover, R., Arimoto, R., Maxwell, J., Fields, S.Z., Charifson, P., Penney, M.S., Tanner, K. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi122-vi122 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|